K imberly-Clark agreed to buy Kenvue in a cash-and-stock transaction that values the Tylenol maker Kenvue at an enterprise value of about $48.7 billion. Under the terms of the deal, Kenvue …
Kimberly-Clark to Buy Tylenol Maker Kenvue. Why the Stock Market Hates the Deal.
view original post